MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2

被引:1
作者
Liu, Lingqi [1 ]
Chen, Liang [1 ]
Wu, Tianpeng [1 ]
Qian, Huijun [1 ]
Yang, Sixing [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Urol, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2019年 / 11卷 / 08期
关键词
Renal cell carcinoma; MicroRNA-30a-3p; WNT2; DOWN-REGULATION; STEM-CELLS; PROLIFERATION; PROGRESSION; SIGNATURES; EXPRESSION; MIGRATION; GROWTH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression and function of microRNA (miR)-30a-3p in several types of human cancer have been explored. However, the biological function of miR-30a-3p in renal cell carcinoma (RCC) remains largely unknown. In this study, we demonstrate that expression of miR-30a-3p is down-regulated in RCC tissues compared to adjacent normal tissues. Furthermore, ectopic expression of miR-30a-3p significantly suppressed the proliferation, migration, and invasion of a human RCC cell line in vitro, while miR-30a-3p inhibited tumor growth in vivo as well. TargetScan software identified Wnt2 as a potential direct target of miR-30a-3p. To confirm this relationship, Wnt2 was ectopically expressed. The effects of miR-30a-3p on RCC cell proliferation and invasion were subsequently restored. Therefore, the results of this study support an anti-tumor role for miR-30a-3p in ROC progression which is potentially mediated via Wnt2.
引用
收藏
页码:4976 / 4983
页数:8
相关论文
共 26 条
  • [1] Ai GH, 2019, AM J TRANSL RES, V11, P3081
  • [2] Signaling pathways in renal cell carcinoma
    Banumathy, Gowrishankar
    Cairns, Paul
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (07) : 658 - 664
  • [3] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [4] Renal cancer
    Capitanio, Umberto
    Montorsi, Francesco
    [J]. LANCET, 2016, 387 (10021) : 894 - 906
  • [5] MicroRNA expression signatures of stage, grade, and progression in clear cell RCC
    Gowrishankar, Banumathy
    Ibragimova, Ilsiya
    Zhou, Yan
    Slifker, Michael J.
    Devarajan, Karthik
    Al-Saleem, Tahseen
    Uzzo, Robert G.
    Cairns, Paul
    [J]. CANCER BIOLOGY & THERAPY, 2014, 15 (03) : 329 - 341
  • [6] Chinese guidelines on the management of renal cell carcinoma (2015 edition)
    Guo, Jun
    Ma, Jianhui
    Sun, Yan
    Qin, Shukui
    Ye, Dingwei
    Zhou, Fangjian
    He, Zhisong
    Sheng, Xinan
    Bi, Feng
    Cao, Dengfeng
    Chen, Yingxia
    Huang, Yiran
    Liang, Houjie
    Liang, Jun
    Liu, Jiwei
    Liu, Wenchao
    Pan, Yueyin
    Shu, Yongqian
    Song, Xin
    Wang, Weibo
    Wang, Xiuwen
    Wu, Xiaoan
    Xie, Xiaodong
    Yao, Xin
    Yu, Shiying
    Zhang, Yanqiao
    Zhou, Aiping
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (19)
  • [7] Huang CB, 2015, AM J CANCER RES, V5, P1032
  • [8] RETRACTED: MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9 (Retracted Article)
    Jiang, Lining
    Liu, Yabin
    Ma, Can
    Li, Binghui
    [J]. ONCOLOGY LETTERS, 2018, 16 (03) : 3038 - 3044
  • [9] Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
    Jung, Youn-Sang
    Jun, Sohee
    Lee, Sun Hye
    Sharma, Amrish
    Park, Jae-Il
    [J]. ONCOTARGET, 2015, 6 (35) : 37257 - 37268
  • [10] Li K, 2017, AM J TRANSL RES, V9, P4402